Jul 9, 2026
Jul 9, 2026
Jul 9, 2026
Jul 9, 2026
Jul 8, 2026
Jul 8, 2026
Jul 7, 2026
Jul 7, 2026
Pfizer faces a challenging path as its COVID-19 products lose demand and key drug patents near expiration. The implications for investors and industry ripple wider than expected.